# Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

> **NCT00666978** · PHASE4 · COMPLETED · sponsor: **Lisa Sanderson Cox, PhD** · enrollment: 540 (actual)

## Conditions studied

- Bladder Cancer
- Cervical Cancer
- Esophageal Cancer
- Gastric Cancer
- Head and Neck Cancer
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Pancreatic Cancer
- Tobacco Use Disorder

## Interventions

- **BEHAVIORAL:** smoking cessation intervention
- **DRUG:** bupropion hydrochloride
- **GENETIC:** gene expression analysis
- **GENETIC:** polymerase chain reaction
- **OTHER:** counseling intervention
- **OTHER:** educational intervention
- **PROCEDURE:** psychosocial assessment and care

## Key facts

- **NCT ID:** NCT00666978
- **Lead sponsor:** Lisa Sanderson Cox, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 540 (ACTUAL)
- **Last updated:** 2017-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666978, "Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00666978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
